---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-049434"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2026-04-27T23:59:59+00:00"
generated_at: "2026-05-15T03:54:23.706349+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Abbott adds Kevin Conroy to board; shareholders approve 2026 Incentive Stock Program

## Summary
- Kevin Conroy appointed to Abbott's Board of Directors effective April 24, 2026.
- Shareholders approved the 2026 Incentive Stock Program authorizing up to 140 million shares, replacing the 2017 plan.
- Board size increased from 12 to 13 directors via bylaw amendment effective April 24, 2026.
- The 2026 Program has a ten-year term and permits stock options, RSUs, performance awards, and other equity grants.
- All director nominees were elected; Ernst & Young ratified as independent auditor.

## SEC filing metadata
- accession: 0001104659-26-049434
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2026-04-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/0001104659-26-049434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/tm2612318d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-049434
- JSON: https://secwatch.observer/filing/0001104659-26-049434.json
- Plain text: https://secwatch.observer/filing/0001104659-26-049434.txt

## Source-grounded claims
- claim_id: 21c9f50a61d20d64472881a01e00a5a49d09cb09
  claim: ABBOTT LABORATORIES: Board size increased from twelve to thirteen directors (effective 2026-04-24).
  evidence_excerpt: On April 24, 2026, Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s by-laws to provide that Abbott’s Board of Directors shall consist of thirteen persons, effective April 24, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800/000110465926049434/0001104659-26-049434-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.